BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
5/15/2017 6:16:31 AM | Browse: 1547 | Download: 2277
 |
Received |
|
2017-01-22 10:29 |
|
Peer-Review Started |
|
2017-01-22 16:53 |
 |
First Decision by Editorial Office Director |
|
|
|
Return for Revision |
|
2017-02-13 12:59 |
|
Revised |
|
2017-02-19 04:11 |
|
Publication Fee Transferred |
|
2017-04-12 15:01 |
|
Second Decision by Editor |
|
2017-03-09 13:21 |
|
Second Decision by Editor-in-Chief |
|
2017-03-12 17:48 |
|
Final Decision by Editorial Office Director |
|
2017-03-15 10:01 |
|
Articles in Press |
|
2017-03-15 10:01 |
|
Edit the Manuscript by Language Editor |
|
|
|
Typeset the Manuscript |
|
2017-04-22 16:12 |
|
Publish the Manuscript Online |
|
2017-05-15 06:16 |
| ISSN |
1007-9327 (print) and 2219-2840 (online) |
| Open Access |
This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ |
| Copyright |
© The Author(s) 2017. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Gastroenterology & Hepatology |
| Manuscript Type |
Evidence-Based Medicine |
| Article Title |
Antimicrobial susceptibility testing before first-line treatment for Helicobacter pylori infection in patients with dual or triple antibiotic resistance
|
| Manuscript Source |
Unsolicited Manuscript |
| All Author List |
Angel Cosme, Milagrosa Montes, Begoña Ibarra, Esther Tamayo, Horacio Alonso, Usua Mendarte, Jacobo Lizasoan, Marta Herreros-Villanueva and Luis Bujanda |
| Funding Agency and Grant Number |
|
| Corresponding Author |
Dr. Luis Bujanda, Gastroenterology Department, Hospital Universitario Donostia/Instituto Biodonostia, Universidad del País Vasco, Centro de Investigación Biomédica en Red de Enfermedades Hepaticas y Digestivas, Paseo Dr. Beguiristain s/n, 20014 San Sebastián,
Spain. medik@telefonica.net |
| Key Words |
Helicobacter pylori; Resistance; Eradication rate; Antimicrobial susceptibility; Therapies |
| Core Tip |
This study evaluated the efficacy of antimicrobial susceptibility-guided therapy: proton-pump inhibitor and two or three antibiotics for ten days before first-line treatment in patients with dual or triple Helicobacter pylori resistance to clarithromycin, metronidazole and/or levofloxacin. Intention to treat analysis demonstrates that eradication rates in patients with dual Helicobacter pylori resistance are high (around 95%). Cure rate was significantly higher in naive patients with dual resistance compared to those with triple resistance (95% vs 83%). |
| Publish Date |
2017-05-15 06:16 |
| Citation |
Cosme A, Montes M, Ibarra B, Tamayo E, Alonso H, Mendarte U, Lizasoan J, Herreros-Villanueva M, Bujanda L. Antimicrobial susceptibility testing before first-line treatment for Helicobacter pylori infection in patients with dual or triple antibiotic resistance. World J Gastroenterol 2017; 23(18): 3367-3373 |
| URL |
http://www.wjgnet.com/1007-9327/full/v23/i18/3367.htm |
| DOI |
http://dx.doi.org/10.3748/wjg.v23.i18.3367 |
All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.
